Under the new EU Medical Device Regulations, due to go live from May 2020, new medical device identification and traceability measures will become compulsory. Bob Tilling of Kallik explores the issues that compliance preparations have thrown up for manufacturers – particularly in relation to global labelling management – and consider how firms might now overcome these effectively so future waves of regulatory changes aren’t as disruptive.